These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17337109)

  • 1. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2007 Apr; 33(4):584-90. PubMed ID: 17337109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2008 Jun; 34(6):930-7. PubMed ID: 18294757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity.
    McDannold N; Vykhodtseva N; Hynynen K
    Phys Med Biol; 2006 Feb; 51(4):793-807. PubMed ID: 16467579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
    McDannold N; Vykhodtseva N; Raymond S; Jolesz FA; Hynynen K
    Ultrasound Med Biol; 2005 Nov; 31(11):1527-37. PubMed ID: 16286030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and Definity in Mice.
    Bing KF; Howles GP; Qi Y; Palmeri ML; Nightingale KR
    Ultrasound Med Biol; 2009 Aug; 35(8):1298-308. PubMed ID: 19545939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.
    Hynynen K; McDannold N; Vykhodtseva N; Raymond S; Weissleder R; Jolesz FA; Sheikov N
    J Neurosurg; 2006 Sep; 105(3):445-54. PubMed ID: 16961141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Oxygen on Ultrasound-Induced Blood-Brain Barrier Disruption in Mice.
    McDannold N; Zhang Y; Vykhodtseva N
    Ultrasound Med Biol; 2017 Feb; 43(2):469-475. PubMed ID: 27789044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison).
    Hynynen K; McDannold N; Martin H; Jolesz FA; Vykhodtseva N
    Ultrasound Med Biol; 2003 Mar; 29(3):473-81. PubMed ID: 12706199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
    Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison.
    Vykhodtseva N; McDannold N; Hynynen K
    Ultrasound Med Biol; 2006 Dec; 32(12):1923-9. PubMed ID: 17169704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.
    Baseri B; Choi JJ; Tung YS; Konofagou EE
    Ultrasound Med Biol; 2010 Sep; 36(9):1445-59. PubMed ID: 20800172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustic techniques for assessing the Optison destruction threshold.
    Porter TM; Smith DA; Holland CK
    J Ultrasound Med; 2006 Dec; 25(12):1519-29. PubMed ID: 17121946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study.
    Hyvelin JM; Gaud E; Costa M; Helbert A; Bussat P; Bettinger T; Frinking P
    J Ultrasound Med; 2017 May; 36(5):941-953. PubMed ID: 28240842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inertial cavitation dose produced in ex vivo rabbit ear arteries with Optison by 1-MHz pulsed ultrasound.
    Tu J; Matula TJ; Brayman AA; Crum LA
    Ultrasound Med Biol; 2006 Feb; 32(2):281-8. PubMed ID: 16464673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.
    Hynynen K; McDannold N; Sheikov NA; Jolesz FA; Vykhodtseva N
    Neuroimage; 2005 Jan; 24(1):12-20. PubMed ID: 15588592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2008 May; 34(5):834-40. PubMed ID: 18207311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optison (FS069) disrupts the blood-brain barrier in rats.
    Mychaskiw G; Badr AE; Tibbs R; Clower BR; Zhang JH
    Anesth Analg; 2000 Oct; 91(4):798-803. PubMed ID: 11004029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface Charge Measurement of SonoVue, Definity and Optison: A Comparison of Laser Doppler Electrophoresis and Micro-Electrophoresis.
    Ja'afar F; Leow CH; Garbin V; Sennoga CA; Tang MX; Seddon JM
    Ultrasound Med Biol; 2015 Nov; 41(11):2990-3000. PubMed ID: 26318559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles.
    Park J; Zhang Y; Vykhodtseva N; Akula JD; McDannold NJ
    PLoS One; 2012; 7(8):e42754. PubMed ID: 22912733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain.
    Kovacs ZI; Tu TW; Sundby M; Qureshi F; Lewis BK; Jikaria N; Burks SR; Frank JA
    Theranostics; 2018; 8(17):4837-4855. PubMed ID: 30279741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.